Highlights of the Advanced Therapeutics in Movement and Related Disorders Congress: Jean Hubble, MD

WATCH TIME: 3 minutes

“Being in the room at this congress with APPs, fellows, and senior residents has just been so exciting. I’ve learned so much from them, as well, particularly the APPs because they see medicine and the care of these individuals in a much different way than I do, either in my role back as an academician or in industry.”

At the 2022 Advanced Therapeutics in Movement and Related Disorders (ATMRD) Congress in Washington, DC, June 17-19, hundreds of clinicians—physicians, advanced practice providers (APPs), residents, and the like—came together to learn and share updates on the latest therapeutic advances in care for patients with disorders such as Parkinson disease or essential tremor. Spanning several days, some of the top experts in the field offered their perspectives to eager crowds of clinicians, both experienced and new to the field.

For Jean Hubble, MD, semi-retired neurologist and consultant, PMD Alliance, this experience was particularly helpful. She highlighted the importance of having a variety of care team members involved, and the insight that can be gleaned from hearing about the management paradigm from the various perspectives and approaches these individuals take to these patients.

Hubble, who spent many years in academic clinical practice as well as working in the pharmaceutical industry, sat down with the PMD Alliance while at the meeting to also offer her advice to the younger clinicians in attendance. She specifically focused on the importance of remaining homed in on the patients, improving quality of life, and developing personalized approaches.

Click here for more coverage of ATMRD 2022.